Biofidelity Email Format
Biotechnology ResearchEngland, United Kingdom11-50 Employees
Biofidelity is a biotechnology research company based in Cambridge, England, focused on advancing access to genomics through novel molecular technologies that simplify genomic analysis. The company aims to provide the information clinicians need to make better decisions and improve patient outcomes, with ambitions that extend beyond oncology. It has developed Aspyre-Lung, a lung cancer assay designed for precision medicine and used in liquid biopsy workflows. Biofidelity operates a CLIA-certified laboratory in North Carolina and collaborates with clinical trial services to broaden the reach of genomic testing. In January 2025, Biofidelity announced an integration with CellCarta Group to incorporate the Aspyre Lung assay into CellCarta's clinical trial services, expanding access to genomic testing worldwide.